The aromatase inhibitors stops the production of estrogen and acts by blocking the enzyme aromatase, which turns the hormone androgen into estrogen in the body, resulting in less estrogen and in turn impair growth of hormone‐receptor‐positive BC cells. The gene discussed is CYP19A1; the disease is breast cancer.